nach oben

Journal of Gastrointestinal Cancer

Erschienen in:

02.09.2017 | Case Report

Giant Hepatic Adenoma in a 12-Year-Old Girl

verfasst von: Hemant Kumar Singh, Shraddha Patkar, A. M. Polnaya, Mukta Ramadwar, Mahesh Goel

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Hepatic adenomas (HA) are benign tumours and constitute 2% of all the liver tumours with an annual incidence of 3–4 per million in Europe and North America [1]. There has been an increase in incidence owing to increase in the use of oestrogen-based contraceptive medication and increased detection due to widespread use of imaging modalities. The common predisposing factor for hepatic adenoma is the use of oestrogen-based oral contraceptive pills. Here, we present a case of giant hepatic adenoma in a young girl in whom no predisposing factors could be identified. …

Rooks JB, Ory HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma-The role of oral contraceptive use. Jr.JAMA. 1979 Aug 17;242(7):644–8 https://doi.org/10.1001/jama.1979.03300070040020

Edmondson HA. Tumours of the liver and intrahepatic bile ducts. section 7, fascicle 25. Atlas of tumour pathology. Washington: Armed Forces Institute of Pathology; 1958.

Baum BJJ, Holtz F, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet. 1973;2(7835):926–9. https://doi.org/10.1016/S0140-6736(73)92594-4.CrossRefPubMed

Rosenberg L. The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception. 1991;43(6):643–52. https://doi.org/10.1016/0010-7824(91)90007-3.

Carrasco D, Barrachina M, Prieto M, Berenguer J. Epidemiology of hepatocellular adenoma-The role of oral contraceptive use. N Engl J Med. 1984;310(17):1120–1. https://doi.org/10.1056/NEJM198404263101716.CrossRefPubMed

Coombes GB, Reiser J, Paradinas FJ. An androgen-associated hepatic adenoma in a trans-sexual., Burn I. Br J Surg. 1978;65(12):869–70. https://doi.org/10.1016/0010-7824(91)90007-3.CrossRefPubMed

Fermand JP, Levy Y, Bouscary D, et al. Danazol-induced hepatocellular adenoma. Am J Med. 1990;88(5):529–30. https://doi.org/10.1016/0002-9343(90)90434-F.CrossRefPubMed

Richter WO, Ritter MM, Wiebecke B, et al. Klinefelter's syndrome and liver adenoma. U. J Clin Gastroenterol. 1991;13(2):214–6. https://doi.org/10.1097/00004836-199104000-00020

Alshak NS, Cocjin J, Podesta L, et al. Hepatocellular adenoma in glycogen storage disease type IV. Arch Pathol Lab Med. 1994;118(1):88–91. https://doi.org/10.1136/adc.82.6.479.CrossRefPubMed

10.

Lack EE, Ornvold K. Focal nodular hyperplasia and hepatic adenoma: a review of eight cases in the pediatric age group. J Surg Oncol. 1986;33(2):129–35. https://doi.org/10.1002/jso.2930330217.

11.

Rosencrantz RA, Wu Y, Sonke PY, et al. Giant hepatocellular adenoma in a previously obese thirteen-year-old boy. Ann Hepatol. 2015;14(4):559–63.CrossRef

12.

Flowers BF, McBurney RP, Vera SR. Ruptured hepatic adenoma. A spectrum of presentation and treatment. Am Surg. 1990;56(6):380–3.PubMed

13.

Stoot JHMB, Coelen RJS, de Jong MC, et al. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford). 2010;12(8):509–22. https://doi.org/10.1111/j.1477-2574.2010.00222.x.CrossRef

14.

Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology. 2006;43(3):515–24. https://doi.org/10.1002/hep.21068.CrossRefPubMed

15.

Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology. 2009;50(2):481–9. https://doi.org/10.1002/hep.22995.CrossRefPubMed

16.

Erdogan D, van Delden OM, Busch OR, et al. Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas. Cardiovasc Intervent Radiol. 2007;30(6):1252–8. https://doi.org/10.1007/s00270-007-9108-4.CrossRefPubMed

17.

Karkar AM, et al. Management of hepatocellular adenoma: comparison of resection, embolization and observation. HPB (Oxford). 2013;15(3):235–43. https://doi.org/10.1111/j.1477-2574.2012.00584.x.CrossRef

18.

Deodhar A, Brody LA, Covey AM, et al. Bland embolization in the treatment of hepatic adenomas: preliminary experience. J Vasc Interv Radiol. 2011;22(6):795–799; quiz 800. https://doi.org/10.1016/j.jvir.2011.02.027.CrossRefPubMed

Titel: Giant Hepatic Adenoma in a 12-Year-Old Girl
verfasst von: Hemant Kumar Singh
Shraddha Patkar
A. M. Polnaya
Mukta Ramadwar
Mahesh Goel
Publikationsdatum: 02.09.2017
Verlag: Springer US
Erschienen in: Journal of Gastrointestinal Cancer / Ausgabe 1/2019
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI: https://doi.org/10.1007/s12029-017-9999-5

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Giant Hepatic Adenoma in a 12-Year-Old Girl

Excerpt

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2019

Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases

A Real-World Comparison of FOLFIRINOX, Gemcitabine Plus nab-Paclitaxel, and Gemcitabine in Advanced Pancreatic Cancers

Gallbladder Adenocarcinoma as the First Manifestation of Germline BRCA1 Mutation

Progression-Free Survival in Patients Receiving Chemotherapy Alone (C) or Chemotherapy with Bevacizumab (CB) for First-Line Treatment of KRAS Mutant Metastatic Colorectal Cancer in Community Oncology Settings

Therapeutic Challenges in the Management of Bleeding Duodenal Gastrointestinal Stromal Tumor: a Case Report and Review of Literature

Disregulation of miR-216a and miR-217 in Gastric Cancer and Their Clinical Significance

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie